Health Sensei Biotherapeutics to Present Preclinical Data for SNS-101, a Conditionally Active… James Pereira Sep 22, 2022 BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company… Read More...
Health MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance… James Pereira Mar 8, 2022 Sanjay Keswani, MBBS, FRCP to join company as Chief Medical Officer bringing extensive experience in drug development… Read More...
